Physician profile
Jeffrey Tseng
NPI 1588976880
$3,189.44
in general payments reported to CMS, 2019-2025
39 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $74.78 · 2021: $256 · 2022: $588 · 2023: $551 · 2024: $609 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $659.13 | 2021-2025 | Puraply, Affinity, Apligraf |
| Paratek Pharmaceuticals, INC. | $251.80 | 2023-2025 | Nuzyra |
| Smith+Nephew, INC. | $247.03 | 2019-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Zimmer Biomet Holdings, INC. | $184.08 | 2019-2022 | |
| Biotissue Holdings INC. | $165.31 | 2022-2024 | |
| Integra Lifesciences Corporation | $159.06 | 2019-2023 | Tenoglide |
| Bioventus LLC | $151.10 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Wright Medical Technology, INC. | $130.19 | 2019 | |
| Bsn Medical INC | $98.05 | 2023 | |
| Sandoz INC. | $97.25 | 2019 | |
| Abbvie INC. | $87.57 | 2022-2024 | Dalvance |
| Linvatec Corporation | $72.79 | 2019 | |
| Melinta Therapeutics, LLC | $70.85 | 2019 | |
| Arthrosurface Incorporated | $69.08 | 2019 | |
| Stryker Corporation | $55.54 | 2021-2025 | Variax |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.